Why Qiagen (QGEN) is a Top Momentum Stock for the Long-Term

Company Overview - QIAGEN N.V. is a leading provider of technologies and products for the separation, purification, and handling of nucleic acids DNA/RNA, based in Venlo, the Netherlands [11] - The company offers over 500 proprietary, consumable products and automated solutions for sample collection, focusing on pre-analytical sample preparation and molecular diagnostics [11] Investment Ratings - QGEN currently holds a 3 (Hold) rating on the Zacks Rank, with a VGM Score of B [12] - The stock has a Momentum Style Score of A, indicating strong upward price movement, with shares increasing by 12% over the past four weeks [12] Earnings Estimates - Seven analysts have revised their earnings estimates upwards for QGEN in the last 60 days for fiscal 2024, with the Zacks Consensus Estimate increasing by $0.03 to $2.14 per share [12] - QGEN has an average earnings surprise of 2.6%, suggesting a positive outlook on earnings performance [12] Investment Consideration - With a solid Zacks Rank and high Momentum and VGM Style Scores, QGEN is recommended for investors' consideration [13]